Ascent Pharmaceuticals, Inc. FDA Record
- Latest inspection VAI · Aug 9, 2024
- No warning letters matched by name
Ascent Pharmaceuticals, Inc. has 3 FDA recalls, 9 inspections, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Ascent Pharmaceuticals, Inc." is on file.
- Latest recall
- D-0276-2022 · Class II · Nov 19, 2021
- Latest inspection
- Aug 9, 2024 · VAI
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 3 | Nov 15, 2026 | File dated Nov 10, 2026 | Current |
| 510(k) clearances | 0 | Nov 15, 2026 | File dated Nov 9, 2026 | Current |
| Inspections | 9 | Nov 17, 2026 | Newest record Nov 9, 2026 | Current |
| Compliance actions | 0 | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
FDA record by year
Ascent Pharmaceuticals, Inc.: FDA inspections per year
| Year | Inspections | OAI | Warning letters | Recall records | Class I |
|---|---|---|---|---|---|
| 2026 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 1 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 |
| 2022 | 1 | 0 | 0 | 0 | 0 |
| 2021 | 0 | 0 | 0 | 1 | 0 |
| 2020 | 1 | 0 | 0 | 1 | 0 |
| 2019 | 0 | 0 | 0 | 0 | 0 |
| 2018 | 3 | 0 | 0 | 1 | 0 |
| 2017 | 0 | 0 | 0 | 0 | 0 |
Reviewing Ascent Pharmaceuticals, Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Ascent Pharmaceuticals, Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Recent recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0276-2022 | Class II | Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg/325 mg, 100-count bottle, Rx only… | Nov 19, 2021 |
| D-0097-2021 | Class II | Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg/325mg 100-count bottles, Rx Only… | Oct 26, 2020 |
| D-0248-2018 | Class III | Oxycodone Hydrochloride Tablets, USP 15 mg, 100 count bottles, Rx only, Manufactured for Camber… | Jan 22, 2018 |
Recent FDA inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| Aug 9, 2024 | Central Islip, NY | Drugs | Voluntary Action Indicated (VAI) | 3009518416 |
| Sep 15, 2022 | Central Islip, NY | Drugs | Voluntary Action Indicated (VAI) | 3009518416 |
| Oct 13, 2020 | Central Islip, NY | Drugs | Voluntary Action Indicated (VAI) | 3009518416 |
| Nov 7, 2018 | Central Islip, NY | Drugs | No Action Indicated (NAI) | 3009518416 |
| Jul 27, 2018 | Central Islip, NY | Drugs | No Action Indicated (NAI) | 3009518416 |
| Feb 21, 2018 | Central Islip, NY | Drugs | No Action Indicated (NAI) | 3009518416 |
| Nov 9, 2015 | Central Islip, NY | Drugs | Voluntary Action Indicated (VAI) | 3009518416 |
| Sep 26, 2013 | Central Islip, NY | Drugs | Voluntary Action Indicated (VAI) | 3009518416 |
| Dec 6, 2012 | Central Islip, NY | Drugs | Voluntary Action Indicated (VAI) | 3009518416 |
- NAI
- No objectionable conditions or practices were found during the inspection.
- VAI
- Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
- OAI
- Regulatory and/or administrative actions are recommended.
FDA-inspected facilities
| Facility | Location | Inspections | Latest |
|---|---|---|---|
| FEI 3009518416 | Central Islip, NY | 9 | Aug 9, 2024 |
Ascent Pharmaceuticals, Inc. and the FDA: common questions
Has Ascent Pharmaceuticals, Inc. received an FDA warning letter?
No FDA warning letter addressed to the name "Ascent Pharmaceuticals, Inc." is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.
Has Ascent Pharmaceuticals, Inc. received an FDA Form 483?
FDA has not published a Form 483 for "Ascent Pharmaceuticals, Inc." in its reading room. FDA publishes some Form 483s, not all of them.
When did the FDA last inspect Ascent Pharmaceuticals, Inc.?
The most recent FDA inspection on file ended Aug 9, 2024 at Central Islip, NY and was classified VAI. FDA has 9 inspections of Ascent Pharmaceuticals, Inc. on file.
Has Ascent Pharmaceuticals, Inc. had an FDA recall?
Yes. Ascent Pharmaceuticals, Inc. has 3 FDA recalls on record. The most recent started Nov 19, 2021.
Need more than this page shows? Ask about Ascent Pharmaceuticals, Inc. in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.